Skip to content
DraconiticResearch
Search Sources API
190,332 studies31 sourcesUpdated 22 min ago
PreprintCC BY-NC-NDHAL

MPRAGE-derived quantitative T 1 mapping to assess diffuse white matter alterations in multiple sclerosis

Abstract

Background Multiple sclerosis (MS) is characterized by focal white matter (WM) lesions, but subtle damage also occurs in normal-appearing white matter (NAWM). We developed a method to generate quantitative T 1 maps from MPRAGE (Magnetization Prepared Rapid Gradient Echo) images and evaluated its ability to detect NAWM abnormalities across different MS phenotypes. Methods T 1 maps were derived from MPRAGE using a theoretical signal model and compared with MP2RAGE (Magnetization Prepared 2 Rapid Gradient Echoes) T 1 values in four healthy volunteers. The method was then applied to 87 MS patients, divided into clinically isolated syndrome (CIS), relapsing–remitting MS (RRMS), and primary progressive MS (PPMS), with age- and sex-matched healthy controls. T 1 was measured in NAWM and lesions. Histogram analysis provided mean T 1 , full width at half maximum (FWHM), and skewness. Results In healthy volunteers, T 1 values matched MP2RAGE. In controls matched to the MS cohort, T 1 increased with age (r = 0.35, p < 0.05). CIS patients showed no significant differences in any metric. RRMS and PPMS patients showed unchanged mean NAWM T 1 but significantly different distributions, with higher FWHM (p<0.05) and skewness (p<0.001). An increase in T 1 values was observed in MS lesions compared to NAWM in all groups. Conclusion This study confirms the feasibility of deriving quantitative T 1 maps from standard MPRAGE, offering reliable information to facilitate MS monitoring without additional acquisitions.

Related

  1. Establishing the Minimal Clinically Important Difference (MCID) for Smartphone-Derived Gait Measures in Multiple Sclerosis
    Mike D Rinderknecht, Bernhard Fehlmann, Dimitar Stanev +7
    arXivPreprintCC BY-NC-ND 4.0Full textBioinformatics & computational biologyBiological & medical physicsarXiv
  2. Pathophysiology and imaging of early memory impairment in multiple sclerosis
    Thomas Tourdias
    GliaPeer-reviewedLicence not statedNeuroscienceHAL
  3. Neuroinflammatory Imaging Biomarkers: Relevance to Multiple Sclerosis and its Therapy
    Thomas Tourdias, Vincent Dousset
    NeurotherapeuticsPeer-reviewedLicence not statedFull text30 citedNeuroscienceHAL
  4. Multiplex immunohistochemistry of chronic active multiple sclerosis lesions links fibroblast-associated vessels with immune cell cuffs
    R. P. Gorter, E. Liang, M. Goiko +1
    bioRxivPreprintAll rights reservedFull textNeurosciencebioRxiv
  5. Engineering human myelin microphysiological systems for testing patient treatment response in multiple sclerosis
    C. Tian, Z. Ao, H. Cai +7
    bioRxivPreprintAll rights reservedFull textSystems & synthetic biologybioRxiv
BibTeX
@misc{lavielle2026mpragederived,
  title = {{MPRAGE-derived quantitative T 1 mapping to assess diffuse white matter alterations in multiple sclerosis}},
  author = {Audrey Lavielle and Fanny Munsch and Aurélie Ruet and Thomas Tourdias and Yannick Crémillieux},
  howpublished = {HAL},
  year = {2026},
  month = may,
  doi = {10.64898/2026.05.04.26351019},
  url = {https://hal.science/hal-05760897v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - MPRAGE-derived quantitative T 1 mapping to assess diffuse white matter alterations in multiple sclerosis
AU  - Audrey Lavielle
AU  - Fanny Munsch
AU  - Aurélie Ruet
AU  - Thomas Tourdias
AU  - Yannick Crémillieux
PY  - 2026
DA  - 2026/05/10
PB  - HAL
DO  - 10.64898/2026.05.04.26351019
UR  - https://hal.science/hal-05760897v1
AB  - Background Multiple sclerosis (MS) is characterized by focal white matter (WM) lesions, but subtle damage also occurs in normal-appearing white matter (NAWM). We developed a method to generate quantitative T 1 maps from MPRAGE (Magnetization Prepared Rapid Gradient Echo) images and evaluated its ability to detect NAWM abnormalities across different MS phenotypes. Methods T 1 maps were derived from MPRAGE using a theoretical signal model and compared with MP2RAGE (Magnetization Prepared 2 Rapid Gradient Echoes) T 1 values in four healthy volunteers. The method was then applied to 87 MS patients, divided into clinically isolated syndrome (CIS), relapsing–remitting MS (RRMS), and primary progressive MS (PPMS), with age- and sex-matched healthy controls. T 1 was measured in NAWM and lesions. Histogram analysis provided mean T 1 , full width at half maximum (FWHM), and skewness. Results In healthy volunteers, T 1 values matched MP2RAGE. In controls matched to the MS cohort, T 1 increased with age (r = 0.35, p < 0.05). CIS patients showed no significant differences in any metric. RRMS and PPMS patients showed unchanged mean NAWM T 1 but significantly different distributions, with higher FWHM (p<0.05) and skewness (p<0.001). An increase in T 1 values was observed in MS lesions compared to NAWM in all groups. Conclusion This study confirms the feasibility of deriving quantitative T 1 maps from standard MPRAGE, offering reliable information to facilitate MS monitoring without additional acquisitions.
ER  -